{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:47:18Z","timestamp":1790689638792,"version":"4.1.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1097\/inf.0b013e3181910e2d","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T10:30:07Z","timestamp":1242901807000},"page":"412-415","source":"Crossref","is-referenced-by-count":135,"title":["Pharmacokinetics of an Elevated Dosage of Micafungin in Premature Neonates"],"prefix":"10.1097","volume":"28","author":[{"given":"P Brian","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Hope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Arrieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akitsugu","family":"Takada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura L.","family":"Kovanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory L.","family":"Kearns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiji","family":"Sawamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald N.","family":"Buell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel K.","family":"Benjamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20210202","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1542\/peds.110.2.285","article-title":"Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network.","volume":"110","author":"Stoll","year":"2002","journal-title":"Pediatrics"},{"key":"R2-11-20210202","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1542\/peds.2004-2292","article-title":"Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months.","volume":"117","author":"Benjamin","year":"2006","journal-title":"Pediatrics"},{"key":"R3-11-20210202","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0146-0005(03)00066-1","article-title":"Mucocutaneous candidiasis.","volume":"27","author":"Rowen","year":"2003","journal-title":"Semin Perinatol"},{"key":"R4-11-20210202","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/S0140-6736(03)14472-8","article-title":"Echinocandin antifungal drugs.","volume":"362","author":"Denning","year":"2003","journal-title":"Lancet"},{"key":"R5-11-20210202","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1128\/AAC.49.8.3317-3324.2005","article-title":"Safety, tolerability, and pharmacokinetics of Micafungin (FK463) in febrile neutropenic pediatric patients.","volume":"49","author":"Seibel","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"R6-11-20210202","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1128\/AAC.49.4.1331-1336.2005","article-title":"Pharmacokinetic and maximum tolerated dose study of micafungin in combination with fluconazole versus fluconazole alone for prophylaxis of fungal infections in adult patients undergoing a bone marrow or peripheral stem cell transplant.","volume":"49","author":"Hiemenz","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"R7-11-20210202","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1097\/01.inf.0000245103.07614.e1","article-title":"The pharmacokinetics and safety of micafungin, a novel echinocandin, in premature infants.","volume":"25","author":"Heresi","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"R8-11-20210202","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1086\/524063","article-title":"The pharmacokinetics and pharmacodynamics of micafungin in experimental hematogenous Candida meningoencephalitis: implications for echinocandin therapy in neonates.","volume":"197","author":"Hope","year":"2008","journal-title":"J Infect Dis"},{"key":"R9-11-20210202","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0022-3476(05)82674-5","article-title":"Pharmacokinetics, outcome of treatment, and toxic effects of amphotericin B and 5-fluorocytosine in neonates.","volume":"116","author":"Baley","year":"1990","journal-title":"J Pediatr"},{"key":"R10-11-20210202","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/infdis\/155.4.766","article-title":"Pharmacokinetics of amphotericin B in infants and children.","volume":"155","author":"Starke","year":"1987","journal-title":"J Infect Dis"},{"key":"R11-11-20210202","doi-asserted-by":"crossref","first-page":"5092","DOI":"10.1128\/AAC.49.12.5092-5098.2005","article-title":"Population pharmacokinetics of amphotericin B lipid complex in neonates.","volume":"49","author":"Wurthwein","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"R12-11-20210202","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF03190361","article-title":"Pharmacokinetics of fluconazole in young infants.","volume":"24","author":"Nahata","year":"1999","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"R13-11-20210202","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/clpt.1993.147","article-title":"Pharmacokinetics of fluconazole in very low birth weight infants during the first two weeks of life.","volume":"54","author":"Saxen","year":"1993","journal-title":"Clin Pharmacol Ther"},{"key":"R14-11-20210202","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1177\/0091270005279580","article-title":"Pharmacokinetics of micafungin in healthy volunteers, volunteers with moderate liver disease, and volunteers with renal dysfunction.","volume":"45","author":"Hebert","year":"2005","journal-title":"J Clin Pharmacol"},{"key":"R15-11-20210202","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/sj.bmt.1705398","article-title":"A study to determine the safety profile and maximum tolerated dose of micafungin (FK463) in patients undergoing haematopoietic stem cell transplantation.","volume":"38","author":"Sirohi","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"R16-11-20210202","article-title":"Mycamine [package insert].","year":"2005"},{"key":"R17-11-20210202","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1542\/peds.112.3.634","article-title":"Neonatal candidemia and end-organ damage: a critical appraisal of the literature using meta-analytic techniques.","volume":"112","author":"Benjamin","year":"2003","journal-title":"Pediatrics"},{"key":"R18-11-20210202","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1128\/AAC.46.6.1857-1869.2002","article-title":"Comparative antifungal activities and plasma pharmacokinetics of micafungin (FK463) against disseminated candidiasis and invasive pulmonary aspergillosis in persistently neutropenic rabbits.","volume":"46","author":"Petraitis","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"R19-11-20210202","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/00006454-199802000-00013","article-title":"Liposomal amphotericin B treatment for neonatal fungal infections.","volume":"17","author":"Scarcella","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"R20-11-20210202","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/jac\/dkg419","article-title":"Treatment of candidaemia in premature infants: comparison of three amphotericin B preparations.","volume":"52","author":"Linder","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"R21-11-20210202","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1055\/s-2003-40008","article-title":"Neonatal invasive candidiasis: a prospective multicenter study of 118 cases.","volume":"20","author":"Lopez Sastre","year":"2003","journal-title":"Am J Perinatol"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006454-200905000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:49:08Z","timestamp":1786038548000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-200905000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e3181910e2d","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}